| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 8, 2003
Accepted on December 5, 2003
by the CRF/Ucn family of peptides
1 The Clayton Laboratories for Peptide Biology, The Salk Institute For Biological Studies, La Jolla, CA, 92037
* To whom correspondence should be addressed. E-mail: vale{at}salk.edu.
Corticotropin releasing factor (CRF) receptor mediated activation of the extracellular receptor kinases (ERK1/2-p42, 44) has been reported for CRF, urocortin (Ucn-I) and sauvagine. Recently, two new members of the CRF/urocortin family of peptides have been identified, urocortin II(Ucn-II)/stresscopin related peptide and urocortin III(Ucn-III)/stresscopin. Using Chinese hamster ovary cells (CHO) stably expressing CRFR1 and CRFR2
, we show that Ucn-I, Ucn-II and Ucn-III activate ERK1/2-p42, 44 via CRFR2
. CRF and Ucn-I, but not Ucn-II or Ucn-III activates ERK1/2-p42, 44 in CHO cells stably expressing CRFR1. The selectivity of the ligands for CRFR1 and CRFR2
is shown in a time and dose dependent manner. The regulatory mechanisms for ERK1/2-p42, 44 activation by both receptor types are dependent upon phosphatidylinositol (PI)-3 OH kinase, mitogen activated protein kinase kinase (MEK1), and phospholipase C. Raf-1 kinase, tyrosine kinases and possibly intracellular Ca2+ provide regulatory roles for Ucn-I activation of ERK1/2-p42, 44 by CRFR1 and CRFR2
. Studies of the regulation of ERK1/2-p42, 44 by Ucn-I were extended to cell lines that endogenously express CRFR1 (AtT-20 and CATHa cells) and CRFR2 (A7r5 and CATHa cells). Use of the Gi and Go protein inhibitor pertussis toxin showed that ERK1/2-p42, 44 activation by Ucn-I via CRFR1 and CRFR2
are both Gi and/or Go protein dependent. Based on the data in this study, we present putative signaling pathways by which the CRF/Ucn family of peptides activate ERK1/2-p42, 44 by CRF receptors.
This article has been cited by other articles:
![]() |
D. Markovic, A. Punn, H. Lehnert, and D. K. Grammatopoulos Intracellular Mechanisms Regulating Corticotropin-Releasing Hormone Receptor-2{beta} Endocytosis and Interaction with Extracellularly Regulated Kinase 1/2 and p38 Mitogen-Activated Protein Kinase Signaling Cascades Mol. Endocrinol., March 1, 2008; 22(3): 689 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C Moss, P. Anton, T. Savidge, P. Newman, A. S Cheifetz, J. Gay, S. Paraschos, M. W. Winter, M. P Moyer, K. Karalis, et al. Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2{alpha} Gut, September 1, 2007; 56(9): 1210 - 1217. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Wu, P.-q. Yuan, L. Wang, Y. L. Peng, C.-Y. Chen, and Y. Tache Identification and Characterization of Multiple Corticotropin-Releasing Factor Type 2 Receptor Isoforms in the Rat Esophagus Endocrinology, April 1, 2007; 148(4): 1675 - 1687. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Punn, M. A. Levine, and D. K. Grammatopoulos Identification of Signaling Molecules Mediating Corticotropin-Releasing Hormone-R1{alpha}-Mitogen-Activated Protein Kinase (MAPK) Interactions: The Critical Role of Phosphatidylinositol 3-Kinase in Regulating ERK1/2 But Not p38 MAPK Activation Mol. Endocrinol., December 1, 2006; 20(12): 3179 - 3195. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kokkotou, D. Torres, A. C. Moss, M. O'Brien, D. E. Grigoriadis, K. Karalis, and C. Pothoulakis Corticotropin-releasing hormone receptor 2-deficient mice have reduced intestinal inflammatory responses. J. Immunol., September 1, 2006; 177(5): 3355 - 3361. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Hillhouse and D. K. Grammatopoulos The Molecular Mechanisms Underlying the Regulation of the Biological Activity of Corticotropin-Releasing Hormone Receptors: Implications for Physiology and Pathophysiology Endocr. Rev., May 1, 2006; 27(3): 260 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chen, M. Perrin, B. Brar, C. Li, P. Jamieson, M. DiGruccio, K. Lewis, and W. Vale Mouse Corticotropin-Releasing Factor Receptor Type 2{alpha} Gene: Isolation, Distribution, Pharmacological Characterization and Regulation by Stress and Glucocorticoids Mol. Endocrinol., February 1, 2005; 19(2): 441 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Nanda, P. H. Roseboom, G. A. Nash, J. M. Speers, and N. H. Kalin Characterization of the Human Corticotropin-Releasing Factor2(a) Receptor Promoter: Regulation by Glucocorticoids and the Cyclic Adenosine 5'-Monophosphate Pathway Endocrinology, December 1, 2004; 145(12): 5605 - 5615. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |